Literature DB >> 17350261

Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3.

Han-Cheng Zhang1, Llorente V R Boñaga, Hong Ye, Claudia K Derian, Bruce P Damiano, Bruce E Maryanoff.   

Abstract

Novel bis(indolyl)maleimide pyridinophanes 3, 9a, 9b, 10a, 10b, and 11 were prepared by cobalt-mediated [2+2+2] cycloaddition of an appropriate alpha,omega-diyne with an N,N-dialkylcyanamide. These macrocyclic heterophanes were found to be potent, selective inhibitors of glycogen synthase kinase-3beta. An X-ray structure of a co-crystal of GSK-3beta and 3 (IC(50)=3nM) depicts the hydrogen bonding and hydrophobic interactions in the ATP-binding pocket of this serine/threonine protein kinase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350261     DOI: 10.1016/j.bmcl.2007.02.059

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  Functionalized ionic liquid-assisted chromatography-free synthesis of bis(indolyl)methanes.

Authors:  Sunita Choudhary; Khima Pandey; Saroj Budania; Anil Kumar
Journal:  Mol Divers       Date:  2017-01-11       Impact factor: 2.943

2.  Nickel-Catalyzed [2+2+2] Cycloaddition of Diynes and Cyanamides.

Authors:  Ryan M Stolley; Michael T Maczka; Janis Louie
Journal:  European J Org Chem       Date:  2011-07

3.  Binding of BIS like and other ligands with the GSK-3β kinase: a combined docking and MM-PBSA study.

Authors:  Nihar R Jena
Journal:  J Mol Model       Date:  2011-05-11       Impact factor: 1.810

4.  Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3β.

Authors:  G Ekin Atilla-Gokcumen; Luigi Di Costanzo; Eric Meggers
Journal:  J Biol Inorg Chem       Date:  2010-09-07       Impact factor: 3.358

5.  Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3beta inhibitors.

Authors:  Ki Hwan Kim; Irina Gaisina; Franck Gallier; Denise Holzle; Sylvie Y Blond; Andrew Mesecar; Alan P Kozikowski
Journal:  J Mol Model       Date:  2009-05-14       Impact factor: 1.810

6.  Extremely tight binding of a ruthenium complex to glycogen synthase kinase 3.

Authors:  G Ekin Atilla-Gokcumen; Nicholas Pagano; Craig Streu; Jasna Maksimoska; Panagis Filippakopoulos; Stefan Knapp; Eric Meggers
Journal:  Chembiochem       Date:  2008-12-15       Impact factor: 3.164

Review 7.  Glycogen synthase kinase 3: more than a namesake.

Authors:  Geetha Vani Rayasam; Vamshi Krishna Tulasi; Reena Sodhi; Joseph Alex Davis; Abhijit Ray
Journal:  Br J Pharmacol       Date:  2009-03-04       Impact factor: 8.739

8.  GSK-3β: A Bifunctional Role in Cell Death Pathways.

Authors:  Keith M Jacobs; Sandeep R Bhave; Daniel J Ferraro; Jerry J Jaboin; Dennis E Hallahan; Dinesh Thotala
Journal:  Int J Cell Biol       Date:  2012-05-21

Review 9.  Selected synthetic strategies to cyclophanes.

Authors:  Mukesh Eknath Shirbhate; Gopalkrushna T Waghule; Sambasivarao Kotha
Journal:  Beilstein J Org Chem       Date:  2015-07-29       Impact factor: 2.883

10.  Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models.

Authors:  Thomas Kramer; Boris Schmidt; Fabio Lo Monte
Journal:  Int J Alzheimers Dis       Date:  2012-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.